| Primary information |
|---|
| sequence ID | Seq_2211 |
| Peptide sequence | FLAEGGG |
| CancerPDF_ID | CancerPDF_ID8513, CancerPDF_ID11447, |
| PMID | 23667664,26992070 |
| Protein Name | Fibrinogen alpha,Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Serum,Serum |
| M/Z | 649.31,649.30714 |
| Charge | 1,NA |
| Mass (in Da) | 650.71,NA |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,LC-MS |
| Peptide Identification technique | FT-ICR MS/MS + nano-HPLC,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID8513, CancerPDF_ID11447, |
| p-Value | NA,NA |
| Software | MASCOT,SEQUEST and Maxquant |
| Length | 7,7 |
| Cancer Type | "Breast cancer, Lung cancer, Rectal cancer",Melanoma |
| Database | NA,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",8 cancer samples and 4 healthy samples |
| Regulation | NA,"Present in 7 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 437539
462581
|